Results 51 to 60 of about 56,302,346 (288)

Real‐World Pediatric Blinatumomab Administration: Access to Outpatient Care Delivery and Impact of a Hospital‐Dispensed Model

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Blinatumomab has been shown to be highly effective for patients with pediatric B‐ALL and has recently become standard of care therapy. Due to its past use in the clinical trial setting, there is limited information available about real‐world administration.
Katelyn Oranges   +12 more
wiley   +1 more source

Clinical Insights Into Hypercalcemia of Malignancy in Childhood

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Hypercalcemia of malignancy (HCM) is a rare but life‐threatening metabolic emergency in children that occurs in less than 1% of pediatric cancer cases, with a reported incidence ranging from 0.4% to 1.0% across different studies. While it is observed in 10%–20% of adult malignancies, pediatric HCM remains relatively uncommon.
Hüseyin Anıl Korkmaz
wiley   +1 more source

Buchbesprechung

open access: yesJournal of Applied Botany and Food Quality, 2012
• Handbuch des Arznei- und Gewürzpflanzenanbaus (Band 2), Grundlagen des Arznei- und Gewürzpflanzenanbaus II • Arzneibuch der chinesischen Medizin / Erich A.
different authors
doaj  

Employing Sisko non-Newtonian model to investigate the thermal behavior of blood flow in a stenosis artery: Effects of heat flux, different severities of stenosis, and different radii of the artery

open access: yesAlexandria Engineering Journal, 2023
In this paper, a numerical investigation is carried out to study the blood flow behavior within the stenosis artery. An artery is under applying a constant heat flux on the boundary walls in this simulation.
MA Haowei   +11 more
doaj   +1 more source

Survival Outcomes and Complications Among Canadian Children With Retinoblastoma: A Population‐Based Report From CYP‐C

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Retinoblastoma (RB) is the most common pediatric ocular cancer, yet population‐based data on survival and risk factors remain limited. This study aimed to describe survival in a large national RB cohort and identify predictors of death and complications.
Samuel Sassine   +14 more
wiley   +1 more source

Personalized Selumetinib Dosing in Pediatric Neurofibromatosis Type 1: Insights From a Pilot Therapeutic Drug Monitoring Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Objective To evaluate selumetinib exposure using therapeutic drug monitoring (TDM) in pediatric patients with neurofibromatosis type 1 (NF1) and plexiform neurofibromas (PN), assess interpatient pharmacokinetic variability, and explore the relationship between drug exposure, clinical response, and adverse effects.
Janka Kovács   +8 more
wiley   +1 more source

Long-term foster care: different needs, different outcomes [PDF]

open access: yes, 2011
This brief examines where foster children are living four years after removal from their homes and the characteristics of these children and their placements. Understanding whether child characteristics such as age or emotional or behavioral problems are
Mattingly, Marybeth J., Walsh, Wendy A.
core   +1 more source

Graph-different permutations

open access: yes, 2007
We strengthen and put in a broader perspective previous results of the first two authors on colliding permutations.
Körner, János   +2 more
core   +1 more source

Adherence to Protocol Recommendations for Children With Wilms Tumour in Two Consecutive Studies in the United Kingdom and Ireland—Does Variation Matter?

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background and Aims Wilms tumour (WT) has excellent event‐free and overall survival (OS). However, small differences exist between countries participating in the same international study. This led us to examine variation in adherence to protocol recommendations as a potential contributing factor.
Suzanne Tugnait   +23 more
wiley   +1 more source

68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer

open access: yesJournal of Nuclear Medicine, 2019
The recent development of quinoline-based PET tracers that act as fibroblast-activation-protein inhibitors (FAPIs) demonstrated promising preclinical and clinical results.
C. Kratochwil   +17 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy